SNCA and Parkinson disease: To this end, mdivi-1, an inhibitor of the mitochondrial fission GTPase Drp1, has been used to inhibit mitochondrial fragmentation in an α-synuclein rat model of PD, reducing neurodegeneration, α-synuclein aggregation, mitochondrial dysfunction and oxidative stress (Bido et al., 2017).